Home > Healthcare > Analytical Instruments > Immunoassay > Immunoassay Market

Immunoassay Market Share

Report ID: GMI8041
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Immunoassay Market Share

These players are developing innovative diagnostic solutions through partnerships and launch initiatives to meet the evolving healthcare demands. These companies are also continuously investing in R&D to enhance immunoassay technologies for driving future advancements in diagnostic accuracy and efficiency.

Immunoassay Market Companies

Foremost players operating in the immunoassay industry are as mentioned below:

Abbott Laboratories
Agilent Technologies, Inc.
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
Hologic Inc.
Luminex Corporation
PerkinElmer, Inc.
QIAGEN
Sysmex Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Immunoassay Market size was valued at over USD 31.3 billion in 2023 and is estimated to expand at 5.3% CAGR from 2024 to 2032 due to the rise in partnerships and collaborations focused on innovative diagnostics and therapeutic solutions.

The reagents & kits segment in the market is poised to expand at 5.1% CAGR from 2024 to 2032, fueled by the rising usage of immunoassay reagents & kits as integral components of immunoassay procedures to facilitate the detection of specific biomarkers.

North America immunoassay market size is expected to record 5% CAGR through 2032 driven by the growing demand for innovative diagnostic solutions.

Abbott Laboratories, Agilent Technologies, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Luminex Corporation, PerkinElmer, Inc., QIAGEN, Sysmex Corporation, and Thermo Fisher Scientific Inc.